Menu
GlaxoSmithKline will refund covered entities that purchased certain formulations of a severe asthma treatment in 2022.

GSK Announces Refunds for 340B Overcharges

Shannon Young, Managing Editor 340B Report Views
GlaxoSmithKline (GSK) will refund covered entities that purchased certain formulations of a severe asthma treatment medication in the third quarter [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

340B ESP Updates Claims Submission Policy, Stakeholders Voice Concerns About Compliance

Organon Partially Exempts Missouri, Minnesota Providers from 340B Contract Pharmacy Restrictions

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live